Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 144 results found. Search for [ Lupin net profit ]

Results 1 to 21 of 144
BusinessToday.In
November 11, 2019
Amara Raja's stock opened with a gain of 3.36% today and later jumped 11.58% to touch the intraday high of Rs 729.75 on the BSE


BusinessToday.In
November 11, 2019
The 'Advertising & Media' sector firm also reported a healthy  evenue from operations that surged 40.4% to Rs 84.7 crore as against Rs 60.3 crore in the same quarter last year


PB Jayakumar
New Delhi, November 8, 2019
Sun Pharma Q2 results: The drugmaker, which earns 37 per cent of its business from the US market, earned Rs 2,389.77 crore from the sale of formulations in the US in Q2FY20 against Rs 2397 crore in the corresponding quarter of the previous year


PTI
November 8, 2019
Revenue from operations stood at Rs 4,007.63 crore as against Rs 3,946.77 crore in the same period a year ago, a growth of 1.57 per cent


BusinessToday.In
November 8, 2019
The share purchase by Jhunjhunwala comes at a time when YES Bank finds itself on a sticky wicket in terms of its financial position


BusinessToday.In
New Delhi, November 7, 2019
HPCL Q2 results: Total income in July-September dipped 9.40 per cent to Rs 66,850.89 crore against Rs 73,789.50 crore in Q2FY19


PB Jayakumar
New Delhi, November 7, 2019
Lupin's net sales for the quarter stood at Rs 4,296 crore, an increase of 10.4 per cent compared to Rs 3,890 crore in the Q2FY19. The company posted a net loss of Rs 127 crore (after exceptional items) in Q2FY20, compared to Rs 266 crore net profit during the same quarter of the previous year


BusinessToday.In
New Delhi, November 6, 2019
Lupin Q2 results: Consolidated revenue from operations of the pharma major increased 10.3 per cent year-on-year (YoY) to Rs 4,359.7 crore in Q2FY20 as against Rs 3,951 crore in Q2FY19


PTI
August 7, 2019
Drug firm Lupin on Wednesday reported a 49.46 per cent rise in consolidated net profit to Rs 303.05 crore for the quarter ended June 30, 2019 on account of robust sales in India and overseas.


PB Jayakumar
New Delhi, July 22, 2019
Zydus Cadila, India's fourth-largest drug company by revenue, is banking big on research of new drugs, even though others have bowed out. Zydus expects the new drug business to grow to Rs 3,500 crore in four-five years


BusinessToday.In
June 7, 2019
Share Market Update: Domestic equity benchmark indices closed marginally higher, after a volatile trading session today.


PB Jayakumar
May 17, 2019
Despite the pressure of business in the US, pharma major Lupin Limited recorded a 5.2 per cent rise in revenues to Rs 16,369.4 crore in FY19


BusinessToday.In
New Delhi, May 15, 2019
Net profit after exceptional items was up 141.4 per cent at Rs 606.60 crore during the financial year ended March 31, 2019; sales for Q4 FY2019 were up 8.7 per cent at Rs 4,325.90 crore compared to Rs 3,978.50 crore in Q4 FY2018;


PTI
May 15, 2019



BusinessToday.In
May 15, 2019
Share Market Updates: Shedding gains of the trading session Wednesday, benchmark indices closed in the red. Other major indices gave up all intraday gains to turn negative in trade as well.


BusinessToday.In
May 14, 2019
Markets Live: While Sensex is trading 263 points higher at 37,354, Nifty is up 83 points to 11,231.70. Sun Pharma, Vedanta and ICICI Bank were the top gainers on Sensex. Tata Steel, Bajaj Auto and Asian Paints were the top losers on Sensex.


BusinessToday.In
May 9, 2019
 Indian equity market extended losses for the seventh consecutive session on Thursday led by decline in Power, Pharma, Energy indices. Escalated trade tensions between China and the US also prompted investors to remain cautious throughout the trading session.


BusinessToday.In
April 24, 2019
Except auto, all other sectoral indices ended in green backed up by gains in bank, IT, energy, telecom and finance.


BusinessToday.In
April 23, 2019
Share Market Updates: Overall 22 stocks out of 30 stocks closed in the red on Sensex and 30 out of 50 stocks closed in the red on NIFTY 50.


Nevin John
New Delhi, February 14, 2019
Sajjan Jindal, Chairman of JSW Steel, buys when everyone sells.


PAGES 1 OF 8  12345